References
- Brandt P., Stenbjerg S. Subcutaneous heparin for thrombosis in pregnant women with hereditary anti-thrombin deficiency. Lancet 1979; i: 100
- Cain M. D., Walters W. A., Catt K. J. Effects of oral contraceptive therapy on the renin-angiotensin system. J Clin Endocrinol Metab 1971; 33: 671
- Conard J., Samama M., Horellou M. H., Zorn J. R., Neau C. Antithrombin III and oral contraception with progestagen-only preparation. Lancet 1979; i: 471
- Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Heamorrh 1965; 13: 516
- Fagerhol M. K., Abilgaard U., Bergsjo P., Jacob-Sen J. H. Oral contraceptives and low antithrombin III concentration. Lancet 1970; i: 1175
- Friedlander M., Laskey N., Silberg S. Effect of es-trogenic substance on blood volume. Endocrinology 1936; 20: 329
- Godal H. C., Abildgaard U. Gelation of soluble fibrin in plasma by ethanol. Scand J Haematol 1966; 3: 342
- Haspels A. A. Interception: post-coital estrogens in 3016 women. Contraception 1976; 14: 375
- Howie P. W., Prentice C. R. M., McNicol G. P. A method of antithrombin estimation using plasma defi-brinated with ancrod. Br J Haematol 1973; 25: 101
- Johnson J. A., Davis J. O., Brown P. R., Wheeler P. D., Witty R. T. Effects of estradiol on sodium and potassium balances in adrenalectomized dogs. Am J Physiol 1972; 223: 194
- Kahlé L. H., Lamping R. J., Ten Cate J. W. Evaluation of an automated antiplasmin assay. Thromb Haemost 1979; 42: 49
- Kahlé L. H., Schipper H. G., Jenkins C. S. P., Ten Cate J. W. Antithrombin III. Evaluation of an automated antithrombin III method. Thromb Res 1978; 12: 1003
- Kobayashi N., Takeda Y. Effects of a large dose of oestradiol on antithrombin III metabolism in male and female dogs. Europ J Clin Invest 1977; 7: 373
- Meade T. W., Haines A. P., North W. R. S., Chak-Rabarti R., Howarth D. J., Stirling Y. HaemostatiC., lipid, and blood pressure profiles of women on oral contraceptives containing 50 μg or 30 μg oestrogen. Lancet 1977; ii: 948
- Morris J. M., van Wagenen G. Interception: the use of postovulatory estrogens to prevent implantation. Am J Obstet Gynecol 1973; 115: 101
- Poller L. Oral contraceptives, blood clotting and thrombosis. Br Med Bull 1978; 34: 151
- Ten Cate J. W., Jenkins C. S. P. The investigation of platelet function. Blood Coagulation and Haemo-stasis, J Thompson, 1979
- van der Meer J., Stoepman-van Dalen E. A., Jan-Sen J. M. S. Antithrombin-III deficiency in a Dutch family. J Clin Path 1973; 26: 532
- van Wijk E. M., Kahlé L. H., Ten Cate J. W. Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants. Clin Chem 1980; 26: 885
- Vessey M. P., Mann J. L. Female sex hormones and thrombosis. Epidemiological aspects. Br Med Bull 1978; 34: 157
- von Kaulla E., von Kaulla K. N. Oral contraceptives and low antithrombin III activity. Lancet 1970; i: 36
- Walters W. A. W., Lim Y. I. Haemodynamic changes in women taking oral contraceptives. J Obstet Gynaec Br Commonw 1970; 77: 1007
- Witten C. L., Bradbury J. T. Hemodilution as a result of estrogen therapy. Estogenic effects in the human female. Proc Soc Exp Biol Med 1951; 78: 626